A $3.5B MC for a biotech start-up stock which isn't even toward the end of Ph2 was very overbought despite the potential market then there were no significant clinical update for over 18 months meant the pps got slowly sold down and once the pps dropped below 10c with a very poorly thought CR, the other RI who bought at the high end sold so they can get the full benefit of the SPP. LT are investing for a T/O from BP, that's when we will win big.
IMUGENE CHART. TA only, page-29987
-
- There are more pages in this discussion • 3,981 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $389.5M |
Open | High | Low | Value | Volume |
5.3¢ | 5.4¢ | 5.2¢ | $384.2K | 7.271M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 1723946 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 905438 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 1723946 | 0.052 |
38 | 4359102 | 0.051 |
48 | 4380509 | 0.050 |
17 | 2263068 | 0.049 |
18 | 930368 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 905438 | 6 |
0.054 | 2937407 | 6 |
0.055 | 987079 | 14 |
0.056 | 2547393 | 9 |
0.057 | 1002553 | 10 |
Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online